Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
1.200
+0.040 (3.45%)
At close: Jun 26, 2026, 4:00 PM EDT
1.199
-0.001 (-0.05%)
After-hours: Jun 26, 2026, 6:18 PM EDT
Filana Therapeutics Employees
As of December 31, 2025, Filana Therapeutics had 20 total employees, including 17 full-time and 3 part-time employees. The number of employees decreased by 10 or -33.33% compared to the previous year.
Employees
20
Change (1Y)
-10
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,895,050
Market Cap
57.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 139 |
| Xilio Therapeutics | 76 |
| aTyr Pharma | 60 |
| PMV Pharmaceuticals | 54 |
| Boundless Bio | 28 |
| MiNK Therapeutics | 15 |
| Context Therapeutics | 15 |
| Cingulate | 14 |
FLNA News
- 16 days ago - Filana Therapeutics Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot - TheFly
- 4 weeks ago - Filana Therapeutics resumed with a Buy at Maxim - TheFly
- 7 weeks ago - Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - GlobeNewsWire
- 7 weeks ago - Filana Therapeutics Earnings release: Q1 2026 - Filings
- 7 weeks ago - Filana Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Filana Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - GlobeNewsWire